Bortezomib ocular toxicities: Outcomes with ketotifen-Reference-Cited by-同舟云学术

Bortezomib ocular toxicities: Outcomes with ketotifen

Published:2019-01-03 Issue:3 Volume:94 Page:E80-E82
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Dennis Michael¹,Maoz Asaf¹^ORCID,Hughes David²,Sanchorawala Vaishali²^ORCID,Sloan J. Mark²,Sarosiek Shayna²^ORCID

Affiliation:

1. Department of Medicine; Boston University School of Medicine and Boston Medical Center; Boston Massachusetts

2. Section of Hematology & Medical Oncology, Department of Medicine; Boston University School of Medicine and Boston Medical Center; Boston Massachusetts

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.25382/fullpdf

Reference6 articles.

1. Multiple myeloma;Rollig;Lancet,2015

2. Induction therapy with bortezomib followed by bortezomib-high dose melphalan and stem cell transplantation for light chain amyloidosis: results of a prospective clinical trial;Sanchorawala;Biol Blood Marrow Transplant,2015

3. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma;Robak;N Engl J Med,2015

4. Chalazia associated with bortezomib therapy for multiple myeloma;Grob;Ophthalmology,2014

5. Association between bortezomib therapy and eyelid chalazia;Fraunfelder;JAMA Ophthalmol,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocular Toxicity of Immunotherapy and Targeted Antineoplastic Agents;Advances in Ophthalmology and Optometry;2023-08

2. Peripheral Ulcerative Keratopathy following Systemic Treatment with Bortezomib: A Case Report;Ocular Immunology and Inflammation;2023-02-13

3. Chalazion in a patient with multiple myeloma treated with bortezomib;BMJ Case Reports;2022-12

4. Meibomian Gland Dysfunction Associated with Bortezomib in a Multiple Myeloma Patient;Journal of the Korean Ophthalmological Society;2022-04-15

5. Leukocyte chemotactic factor 2–related amyloidosis presenting with severe jaundice and hepatic encephalopathy;Clinical Case Reports;2021-12